You are here:
home
> news
Please view the latest news articles from across Europe below. Alternatively, filter by news category or search by keyword.
A team of scientists at GE Global Research, the technology development arm for the GE (NYSE: GE), has launched a study with Memorial Sloan-Kettering Cancer Center, (MSKCC) one of the world's premier cancer centers, to better understand the early stages of colon cancer. The goal is to yield new insights that improve treatment selection and outcomes for cancer patients in the future.
"Information is one of the best weapons we have in the fight against cancer," said John Burczak, Chief Scientist for Molecular Imaging at GE Global Research. "With colon cancer, we know that not all cases in the early stages of the disease are alike. Some are more aggressive than others. Through the promise of molecular analysis, we can identify those patients at higher risk and help ensure they receive the best possible treatment option."
For more details
View the full story here
The information provided is for interest only and is not a substitute for professional medical advice. You should not rely on this information to make or refrain from making any decisions. Always obtain independent professional advice for your own particular health situation.